The company, which plans to liquidate, has $1.3 million in assets and nearly $257 million in liabilities owed to lenders, investors, vendors and employees, according to court filings.
Category: Premium Content
This Scientist-Entrepreneur Is Brewing Prescription Drug Ingredients Like They Were Beer
Backed by $123 million in venture investments, Christina Smolke’s company Anthiea just completed its first scaled production of a key drug ingredient.
Amazon’s Radical Plan For Healthcare: À La Carte Pricing
With Amazon Clinic, patients can see wait times and prices upfront, but there are limits to what it can do to cut down on the $4.3 trillion the U.S. spends on healthcare.
This Scientist Thinks You Should Pay $215 A Month For ‘Good’ Bacteria To Help Control Your Diabetes
Biotech researcher Colleen Cutcliffe designed probiotics to help diabetics lower their blood sugar. Now she’s got a handful of expensive supplements for sale — and Halle Berry on board to help sell them.
This Startup Wants To Fight Bladder Cancer With A Genetically Engineered Virus
CG Oncology, led by Forbes 30 Under 30 alum Arhtur Kuan, has developed a genetically engineered virus to treat bladder cancer.
The MedTech Billionaire Waging A Patent War With Apple
Joe Kiani, the founder and CEO of Masimo, has spent $60 million fighting Apple in court over its smartwatch, as he faces a boardroom battle over his consumer tech push.
ChatGPT Won’t Fix Healthcare, But It Might Save Doctors Some Time
Generative AI is entering the doctor’s office – but it’s not through the front door.
This Startup Wants To Bring Disinfecting UV Light Into “Every Physical Space”
Hospitals have long used ultraviolet light to zap viruses, but the devices were too expensive for business and schools. Spurred by the pandemic, an unlikely trio started R-Zero to develop a lower-cost alternative—and was just featured on our latest lis…
